Seishima R, Hibi T, Takeuchi M, Takemura Y, Maeda H, Kondo M
Surg Today. 2025; .
PMID: 40032678
DOI: 10.1007/s00595-025-03021-1.
Ohta H, Yasu T
Curr Oncol. 2025; 32(2).
PMID: 39996900
PMC: 11854802.
DOI: 10.3390/curroncol32020100.
Ochiai K, Kameda I, Kato Y, Shimizu M, Momosaki R
Prog Rehabil Med. 2025; 10:20250006.
PMID: 39989475
PMC: 11840441.
DOI: 10.2490/prm.20250006.
Endo F, Hiramatsu Y, Ide H
Sci Rep. 2025; 15(1):2411.
PMID: 39827324
PMC: 11742983.
DOI: 10.1038/s41598-025-87072-x.
Masuda S, Fukasawa T, Matsuda S, Yoshida S, Kawakami K
Osteoporos Int. 2025; 36(3):565-567.
PMID: 39777490
DOI: 10.1007/s00198-024-07348-2.
Early prediction of functional impairment at hospital discharge in patients with osteoporotic vertebral fracture: a machine learning approach.
Masuda S, Fukasawa T, Inokuchi S, Otsuki B, Murata K, Shimizu T
Sci Rep. 2024; 14(1):31139.
PMID: 39732765
PMC: 11682089.
DOI: 10.1038/s41598-024-82359-x.
Seasonal Variations in Triptan Prescription in Japan: A Nationwide Time-Series Analysis.
Tatsumoto M, Hirata K, Nakayama T, Yamato K, Sano H, Inuyama L
Brain Behav. 2024; 14(12):e70184.
PMID: 39710991
PMC: 11663837.
DOI: 10.1002/brb3.70184.
Diagnostic validity and solute-corrected prevalence for hyponatremia and hypernatremia among 1 813 356 admissions.
Okada A, Yamana H, Watanabe H, Manaka K, Ono S, Kurakawa K
Clin Kidney J. 2024; 17(12):sfae319.
PMID: 39664986
PMC: 11630772.
DOI: 10.1093/ckj/sfae319.
Impact of Concomitant Prescriptions and Lifestyle Factors on the Initial Course of Newly Diagnosed Inflammatory Bowel Disease.
Morikubo H, Nagahama T, Nagai K, Yamazaki H, Kobayashi T
Inflamm Intest Dis. 2024; 9(1):260-270.
PMID: 39563684
PMC: 11575924.
DOI: 10.1159/000541984.
Current status of serum lithium concentration measurement in Japan.
Ide N, Sako K
PCN Rep. 2024; 3(4):e70037.
PMID: 39554393
PMC: 11564127.
DOI: 10.1002/pcn5.70037.
Trajectory Patterns of Three Lifestyle Behaviors and Subsequent Health Conditions in Japanese Adults: A Retrospective Longitudinal Study Using a Health Checkup Database.
Tajima T, Kanehara R, Fujii M, Tanaka S, Umezawa J, Ohno Y
JMA J. 2024; 7(4):506-517.
PMID: 39513057
PMC: 11543322.
DOI: 10.31662/jmaj.2024-0076.
Association between gastroprotective agents and acute kidney injury in patients receiving non-steroidal anti-inflammatory drugs: Analysis of a Japanese hospital-based database.
Mitsuboshi S, Imai S, Kizaki H, Hori S
Pharmacotherapy. 2024; 44(11):851-860.
PMID: 39400376
PMC: 11586649.
DOI: 10.1002/phar.4617.
The impact of COVID-19 on hay fever treatment in Japan: A retrospective cohort study based on the Japanese claims database.
Akasaki Y, Inomata T, Iwagami M, Sung J, Nagino K, Adachi T
Clin Transl Allergy. 2024; 14(9):e12394.
PMID: 39286886
PMC: 11406147.
DOI: 10.1002/clt2.12394.
Unchanged incidence of major adverse events amidst rising surgical interventions for osteoporotic vertebral fractures, 2015-2021.
Masuda S, Fukasawa T, Otsuki B, Murata K, Shimizu T, Sono T
Arch Osteoporos. 2024; 19(1):71.
PMID: 39107589
DOI: 10.1007/s11657-024-01428-w.
Drug utilization pattern of romosozumab and other osteoporosis treatments in Japan, 2019-2021.
Soen S, Wang A, Hamaya E, Chien H, Lin T
J Bone Miner Metab. 2024; 42(6):653-667.
PMID: 38987505
PMC: 11631996.
DOI: 10.1007/s00774-024-01530-6.
The Prevalence of Duplicate Prescription of Oral Antibiotic Drugs in Outpatient Care among People Insured by Corporate Health Insurance Societies in Japan.
Fujimoto K, Tanihara S
Healthcare (Basel). 2024; 12(11).
PMID: 38891225
PMC: 11171574.
DOI: 10.3390/healthcare12111150.
Impact of Early Rehabilitation after Endovascular Treatment for Peripheral Arterial Disease.
Kato Y, Ushida K, Shimizu M, Momosaki R
Prog Rehabil Med. 2024; 9:20240021.
PMID: 38855421
PMC: 11156502.
DOI: 10.2490/prm.20240021.
Trends in the prevalence and incidence of Crohn's disease in Japan and the United States.
Nakajo K, Yamazaki M, Chung H, Xu Y, Qiu H
Int J Colorectal Dis. 2024; 39(1):61.
PMID: 38676760
PMC: 11055788.
DOI: 10.1007/s00384-024-04636-5.
A cross-sectional survey of hepatitis B virus screening in patients who received immunosuppressive therapy for rheumatoid arthritis in Japan.
Yanagisawa Y, Imai S, Kizaki H, Hori S
J Pharm Health Care Sci. 2024; 10(1):18.
PMID: 38637884
PMC: 11025209.
DOI: 10.1186/s40780-024-00339-9.
A Review of Studies Using Japanese Nationwide Administrative Claims Databases.
Sato S, Yasunaga H
Ann Clin Epidemiol. 2024; 5(2):58-64.
PMID: 38505730
PMC: 10944998.
DOI: 10.37737/ace.23008.